Nebraska Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 6 (86% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 2,045
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 75.43%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 305
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 71.08%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 23.13% 27.21%
White, Hispanic/Latino Patients 41.71% 37.05%
Black/African American, Non-Hispanic/Latino Patients 13.35% 11.15%
Black/African American, Hispanic/Latino Patients 0.98% 1.97%
Asian Patients3 5.38% 6.23%
American Indian/Alaska Native Patients3 0.83% 2.30%
Native Hawaiian/Other Pacific Islander Patients3 0.29% 0.33%
Patients with More than one race3 2.59% 2.95%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 5.87% 4.92%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.79% 2.30%
Unreported/Refused to Report Race and Ethnicity 3.08% 3.61%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 707
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 80.48%
COVID-19 Immunization Series Completed 556
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 90.35%
COVID-19 Immunization Series Additional 438
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 58.80%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 17.40% 8.81% 39.04%
White, Hispanic/Latino Patients 49.50% 57.37% 47.03%
Black/African American, Non-Hispanic/Latino Patients 8.06% 6.83% 3.42%
Black/African American, Hispanic/Latino Patients 0.00% 0.18% 0.68%
Asian Patients3 3.25% 5.04% 1.60%
American Indian/Alaska Native Patients3 0.42% 0.18% 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.14% 0.00% 0.00%
Patients with More than one race3 1.27% 1.80% 0.91%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 9.05% 11.15% 2.05%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 3.25% 3.42% 3.88%
Unreported/Refused to Report Race and Ethnicity 7.64% 5.22% 1.37%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 33.33%
1 to 24 Hours 50.00%
More Than 24 Hours 16.67%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 50.00%
Vaccine confidence 50.00%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 0.00%
None 16.67%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 66.67%
Average Percent of Health Center Visits Conducted Virtually 7.50%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 16.67%
Number of Mobile Van Sites 0
Number of Pop-up Clinics 2
Number of School-Based Vaccination Sites 0

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 83.33%
None 16.67%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 0.00%
Patient awareness/education 16.67%
Staffing capacity 16.67%
Therapy administration/onsite logistics 16.67%
Other 0.00%
None 83.33%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021